PARLIAMENTARY WRITTEN QUESTION
Medical Treatments: Innovation (11 April 2016)

To ask the Secretary of State for Health, whether the consultation on the database created by the Access to Medical Treatments (Innovation) Act 2016 will involve (a) medical research charities, (b) the pharmaceutical sector and (c) the Medicines and Healthcare Products Regulatory Agency.

Asked by:
Jonathan Reynolds (Labour)

The Health and Social Care Information Centre will consult with stakeholders including charities, the relevant Royal Colleges, industry, the Medicines and Healthcare products Regulatory Agency and other relevant bodies in the creation of the Database described in the Act, when the power vested on the Secretary of State is enacted.

Answered by:
George Freeman (Conservative)
18 April 2016